{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:32:21Z","timestamp":1760056341085,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.diagmicrobio.2020.114986","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T20:24:38Z","timestamp":1578601478000},"page":"114986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential impact of IVIG treatment on Lyme serology"],"prefix":"10.1016","volume":"96","author":[{"given":"Andr\u00e1s","family":"Z\u00f3ka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Bek\u0151","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.114986_bb0005","doi-asserted-by":"crossref","unstructured":"Barreiro-Hurl\u00e9 L, Mel\u00f3n-Garc\u00eda S, Seco-Bernal C, Mu\u00f1oz-Turrillas C, Rodr\u00edguez-P\u00e9rez M. Seroprevalencia de enfermedad de Lyme en el suroccidente de Asturias. Enfermedades Infecc Microbiol Cl\u00ednica Published Online First: 2 September 2019. https:\/\/doi.org\/10.1016\/j.eimc.2019.06.010","DOI":"10.1016\/j.eimc.2019.06.010"},{"issue":"Suppl","key":"10.1016\/j.diagmicrobio.2020.114986_bb0010","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.21101\/cejph.a5442","article-title":"Seroprevalence of Lyme disease in Eastern Slovakia","volume":"26","author":"Bu\u0161ov\u00e1","year":"2018","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.diagmicrobio.2020.114986_bb0015","first-page":"114952","article-title":"Impact of IVIG therapy on serologic testing for infectious diseases","author":"Hanson","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"196","key":"10.1016\/j.diagmicrobio.2020.114986_bb0020","first-page":"1036","article-title":"Epitope-specific evolution of human B cell responses to Borrelia burgdorferi VlsE protein from early to late stages of Lyme disease","volume":"1950","author":"Jacek","year":"2016","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.diagmicrobio.2020.114986_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3201\/eid2101.140009","article-title":"Antibodies against Borrelia burgdorferi sensu lato among adults, Germany, 2008\u20132011","volume":"21","author":"Wilking","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.114986_bb0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10096-016-2813-7","article-title":"Prevalence of serological response to Borrelia burgdorferi in farmers from eastern and central Poland","volume":"36","author":"Zaj\u0105c","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319312489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319312489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:56Z","timestamp":1760003636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889319312489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0732889319312489"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.114986","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential impact of IVIG treatment on Lyme serology","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.114986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114952","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114986"}}